Alithia Life Sciences is an Australian owned boutique, full-service capability Contract Research Organization (CRO) launched to support and assist pharmaceutical, biotechnology, device companies and institutional research groups undertaking their project in the Australian region and beyond.

We have an average of 20+ years of operational expertise and industry experience in various therapeutic areas including, first in human studies (FIH), devices, endocrinology, oncology, neurology, gastroenterology, rare and pediatric diseases and vaccines.

Our breath of expertise in the academic, commercial and biotechnology settings can support your project from Phase I through to Phase III.

Our local and global experience includes developing products successfully through to FDA approval, executive management and previous establishment of a successful Contract Research Organization (CRO).